Institutional Biosafety Committee
The Institutional Biosafety Committee (IBC) reviews, approves and provides surveillance of all research protocols involving the use of biohazardous materials including recombinant DNA, agents infectious to humans, animals or plants, and other genetically altered organisms and agents.
|Craig Frank||Chair of IBC, Biological Sciences|
|Evon Hekkala||Biological Sciences|
|Joan Roberts||Natural Science|
|Qize Wei||Biological Sciences|
Pathogenic Agent (human, non-primate, animal, plant) Protocol
National Institutes of Health Institutional Biosafety Committee